secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cadrenal Therapeutics, Inc. (CVKD)
CIK:        0001937993
Form:       8-K
Filed at:   2023-09-08T23:59:59+00:00
Accession:  0001213900-23-075392
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cadrenal Therapeutics receives Nasdaq minimum bid price deficiency notice
-------------------------------------------------------------------------

- Nasdaq notice on Sept 6, 2023, for bid price below $1.00 for 30 consecutive days.
- Company has 180 calendar days until March 4, 2024, to regain compliance.
- To comply, closing bid price must be at least $1.00 for 10 consecutive business days.
- Company may consider options including reverse stock split to regain compliance.
- Delisting not immediate; subject to remaining listing requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937993/000121390023075392/0001213900-23-075392-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937993/000121390023075392/ea184815-8k_cadrenal.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-075392

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer